Goldman Sachs downgraded Magellan Financial to Sell from Neutral with a price target of A$9, down from A$10. The firm downgraded the shares relative to coverage reflecting ongoing downside risk to margins from mix impacts and ongoing weak performance outside Vinva, as well as valuation compared to peers. Capital management and associate performance present risks for the stock going into the result, the analyst tells investors in a research note.